7-106261678-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005746.3(NAMPT):āc.999T>Cā(p.Pro333=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00296 in 1,603,790 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0031 ( 2 hom., cov: 32)
Exomes š: 0.0029 ( 11 hom. )
Consequence
NAMPT
NM_005746.3 synonymous
NM_005746.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0370
Genes affected
NAMPT (HGNC:30092): (nicotinamide phosphoribosyltransferase) This gene encodes a protein that catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein belongs to the nicotinic acid phosphoribosyltransferase (NAPRTase) family and is thought to be involved in many important biological processes, including metabolism, stress response and aging. This gene has a pseudogene on chromosome 10. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 7-106261678-A-G is Benign according to our data. Variant chr7-106261678-A-G is described in ClinVar as [Benign]. Clinvar id is 774661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.037 with no splicing effect.
BS2
High AC in GnomAd4 at 472 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAMPT | NM_005746.3 | c.999T>C | p.Pro333= | synonymous_variant | 8/11 | ENST00000222553.8 | NP_005737.1 | |
NAMPT | XM_047419699.1 | c.999T>C | p.Pro333= | synonymous_variant | 9/12 | XP_047275655.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAMPT | ENST00000222553.8 | c.999T>C | p.Pro333= | synonymous_variant | 8/11 | 1 | NM_005746.3 | ENSP00000222553 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00310 AC: 472AN: 152188Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
472
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00307 AC: 772AN: 251062Hom.: 3 AF XY: 0.00311 AC XY: 422AN XY: 135742
GnomAD3 exomes
AF:
AC:
772
AN:
251062
Hom.:
AF XY:
AC XY:
422
AN XY:
135742
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00295 AC: 4281AN: 1451484Hom.: 11 Cov.: 30 AF XY: 0.00294 AC XY: 2122AN XY: 722830
GnomAD4 exome
AF:
AC:
4281
AN:
1451484
Hom.:
Cov.:
30
AF XY:
AC XY:
2122
AN XY:
722830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00310 AC: 472AN: 152306Hom.: 2 Cov.: 32 AF XY: 0.00314 AC XY: 234AN XY: 74488
GnomAD4 genome
AF:
AC:
472
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
234
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at